Pharm-Olam, IACOR Collaborate on Audit Certification
Until now there has not been an industry standard for clinical research auditing, but CRO Pharm-Olam and IAOCR have addressed that. Pharm-Olam developed a 12-week program, Core Global Competencies for Clinical Research Auditing, which IACOR has independently accredited to ensure consistently high standards of clinical research auditing across the industry. Individuals will be designated as Internationally Qualified Clinical Research Auditors, designated letters of AIACR. Pharm-Olam is funding the program for qualified members of its vendor network; however, the program is available to all individuals to gain the professional status.
For more information, click here.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
